Peer Review reports
From: Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
| Original Submission | ||
|---|---|---|
| 2 Jul 2021 | Submitted | Original manuscript |
| 16 Jul 2021 | Author responded | Author comments - Matthew J. Kling |
| Resubmission - Version 2 | ||
| 16 Jul 2021 | Submitted | Manuscript version 2 |
| 4 Aug 2021 | Reviewed | Reviewer Report |
| 14 Aug 2021 | Reviewed | Reviewer Report |
| 2 Sep 2021 | Author responded | Author comments - Matthew J. Kling |
| Resubmission - Version 3 | ||
| 2 Sep 2021 | Submitted | Manuscript version 3 |
| 8 Sep 2021 | Reviewed | Reviewer Report |
| 11 Sep 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 14 Sep 2021 | Editorially accepted | |
| 26 Sep 2021 | Article published | 10.1186/s12885-021-08782-9 |
You can find further information about peer review here.